New approaches in the management of chronic hepatitis B: role of tenofovir. - Wikidata - wikimedia - TriplyDB

New approaches in the management of chronic hepatitis B: role of tenofovir.

New approaches in the management of chronic hepatitis B: role of tenofovir.

http://www.wikidata.org/entity/Q35026531

about

Immunoregulation of hepatitis B virus infection--rationale and clinical application Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues.

P2860

Q36797085-B3E0CC0A-544C-4650-885C-65EF21F5C6C1 Q38074646-F7623D20-87DE-4CC1-B3AD-2190F36909D9

P2860

New approaches in the management of chronic hepatitis B: role of tenofovir.

http://www.wikidata.org/entity/Q35026531

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

New approaches in the management of chronic hepatitis B: role of tenofovir.

@ast

New approaches in the management of chronic hepatitis B: role of tenofovir.

@en

type

label

New approaches in the management of chronic hepatitis B: role of tenofovir.

@ast

New approaches in the management of chronic hepatitis B: role of tenofovir.

@en

prefLabel

New approaches in the management of chronic hepatitis B: role of tenofovir.

@ast

New approaches in the management of chronic hepatitis B: role of tenofovir.

@en

P1433

Q35026531-55D600D7-803D-41D8-B96E-831344EF7D6A

P1476

Q35026531-646FB4E0-6E1A-43C0-BCDA-9BCEF07339BC

P2093

Q35026531-4E0CED66-2FAC-4E22-8AB2-6A5BA488E359

Q35026531-B7B6E669-BBDE-4593-90D2-888C7F34C7CA

P2860

Q35026531-0355947E-30C7-4856-89CF-0106A68AA2E6

Q35026531-03606C1D-3A81-4391-9DE7-9E29C301D630

Q35026531-06B298F7-421A-455D-83FA-BDAB3A1F726A

Q35026531-09A55C3A-BA6C-461B-B16F-D95B8A3DFA4C

Q35026531-0BFD6584-6918-4239-B4B8-420C24696F15

Q35026531-0C80127D-BE70-4ABB-9DB4-D3CF0033D68A

Q35026531-0E6554F9-891F-4C5B-81FE-24D1612DDBE6

Q35026531-0FE9D315-C64F-479E-8920-29C43C413BF9

Q35026531-10C61AE7-81D9-48BD-B012-9370E60DBFF2

Q35026531-13E1CE02-6CCA-4E3C-9031-B246168D1ECE

P304

Q35026531-D781FA40-7049-4DE7-AB1B-FC63C7F07184

P31

Q35026531-56A04D63-406B-4BA7-9B0C-98D71C82EED7

P356

Q35026531-88ABDEF9-D474-4DC1-9927-688B5783461D

P407

Q35026531-799B7B11-60A5-4BDC-A658-69856F3CC643

P478

Q35026531-1F6857FF-0D8A-49B0-9C1D-947CD800C644

P577

Q35026531-241DFCA7-B5D0-47F9-BCEE-25D652F6A4AA

P698

Q35026531-80BCA8F7-64D5-4087-AEA6-7845E2BB9085

P932

Q35026531-975EBC57-C680-49DA-BC3C-52F38F50F72B

P356

P1433

Infection and Drug Resistance

P1476

New approaches in the management of chronic hepatitis B: role of tenofovir

@en

P2093

Harry LA Janssen

http://www.w3.org/2001/XMLSchema#string

Jurriën Gp Reijnders

http://www.w3.org/2001/XMLSchema#string

P2860

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

Telbivudine versus lamivudine in patients with chronic hepatitis B

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine

Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA

Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine.

Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis.

Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study

Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.

Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults.

P304

13-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IDR.S3918

http://www.w3.org/2001/XMLSchema#string

P407

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21694884

http://www.w3.org/2001/XMLSchema#string

P932

3108728

http://www.w3.org/2001/XMLSchema#string